¹ Andre B. Araujo, Gretchen R. Esche, et al. Prevalence of Symptomatic Androgen Deficiency in Men, The Journal of Clinical Endocrinology & Metabolism, Volume 92, Issue 11, 1 November 2007, Pages 4241–4247
² Rabijewski M, Papierska L, Kozakowski J, Zgliczyński W. The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunctions. Aging Male [Internet]. 2012;15(4):258–62. Available from: http://dx.doi.org/10.3109/13685538.2012.729233
³ Layton JB, Li D, Meier CR, Sharpless JL, Stürmer T, Jick SS, et al. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab [Internet]. 2014;99(3):835–42
⁴ Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care [Internet]. 2011;34(7):1669–75. Available from: http://dx.doi.org/10.2337/dc10-2339
⁵ Indirli R, Lanzi V, Arosio M, Mantovani G, Ferrante E. The association of hypogonadism with depression and its treatments. Front Endocrinol (Lausanne) [Internet]. 2023;14. Available from: http://dx.doi.org/10.3389/fendo.2023.1198437
⁶ Morales A, Bebb RA, Manjoo P, Assimakopoulos P, Axler J, Collier C, et al. Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ [Internet]. 2015;187(18):1369–77. Available from: http://dx.doi.org/10.1503/cmaj.150033
⁷ Morley J. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag [Internet]. 2009;427. Available from: http://dx.doi.org/10.2147/tcrm.s3025